<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">34896007</PMID>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1473-0502</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis</Title>
          <ISOAbbreviation>Transfus Apher Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>COVID-19-associated Evans syndrome: A case report and review of the literature.</ArticleTitle>
        <Pagination>
          <StartPage>103339</StartPage>
          <MedlinePgn>103339</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">103339</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transci.2021.103339</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1473-0502(21)00347-5</ELocationID>
        <Abstract>
          <AbstractText>Evans syndrome is a rare condition characterized by simultaneous or sequential development of autoimmune hemolytic anemia and immune thrombocytopenia (and/or immune neutropenia). Coronavirus disease 2019 (COVID-19) may cause various hematologic conditions, such as coagulation abnormalities (e.g., bleeding or thrombosis) or cell count alterations (e.g., lymphopenia and neutrophilia). COVID-19 may also induce Evans syndrome via immune mechanisms. Here, we describe the case of a patient developing Evans syndrome shortly after COVID-19 infection. Immune thrombocytopenia and warm-type autoimmune hemolytic anemia developed simultaneously, and intravenous immunoglobulin and methylprednisolone were initially administered. Additionally, we intend to review all COVID-19-induced Evans syndrome cases currently present in the literature and emphasize the differences as well as the similarities regarding patient characteristics, relationship to COVID-19 infection, and treatment approach. Since autoimmune cytopenias are frequent in COVID-19 patients, clinicians should pay particular attention to profound and abrupt-onset cytopenias. In these circumstances, hemolysis markers such as lactate dehydrogenase, haptoglobulin, Coombs tests, etc. should be investigated, and the possibility of Evans syndrome should always be considered to ensure prompt and appropriate treatment. These factors are essential to ensure hematologic recovery and prevent complications such as thrombosis.</AbstractText>
          <CopyrightInformation>Copyright © 2021. Published by Elsevier Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Turgutkaya</LastName>
            <ForeName>Atakan</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Adnan Menderes University Hematology Department, Aytepe Mevki, Efeler, PC: 09010, Aydın, Turkey. Electronic address: atakanturgutkaya@yahoo.com.tr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bolaman</LastName>
            <ForeName>Ali Zahit</ForeName>
            <Initials>AZ</Initials>
            <AffiliationInfo>
              <Affiliation>Adnan Menderes University Hematology Department, Aytepe Mevki, Efeler, PC: 09010, Aydın, Turkey. Electronic address: zahitb@yahoo.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yavaşoğlu</LastName>
            <ForeName>İrfan</ForeName>
            <Initials>İ</Initials>
            <AffiliationInfo>
              <Affiliation>Adnan Menderes University Hematology Department, Aytepe Mevki, Efeler, PC: 09010, Aydın, Turkey. Electronic address: dryavas@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Transfus Apher Sci</MedlineTA>
        <NlmUniqueID>101095653</NlmUniqueID>
        <ISSNLinking>1473-0502</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Autoimmune hemolytic anemia</Keyword>
        <Keyword MajorTopicYN="N">Coronavirus disease</Keyword>
        <Keyword MajorTopicYN="N">Direct antiglobulin test</Keyword>
        <Keyword MajorTopicYN="N">Immune thrombocytopenia</Keyword>
        <Keyword MajorTopicYN="N">Intravenous immunoglobulin</Keyword>
      </KeywordList>
      <CoiStatement>None.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>13</Day>
          <Hour>12</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34896007</ArticleId>
        <ArticleId IdType="pmc">PMC8655821</ArticleId>
        <ArticleId IdType="doi">10.1016/j.transci.2021.103339</ArticleId>
        <ArticleId IdType="pii">S1473-0502(21)00347-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Michel M., Chanet V., Dechartres A., Sophie M.A., Piette J., Cirasino L., et al.  The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood. 2009;114:3167–3172. doi: 10.1182/blood-2009-04-215368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2009-04-215368</ArticleId>
            <ArticleId IdType="pubmed">19638626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hadjadj J., Aladjidi N., Fernandes H., Leverger G., Magérus-Chatinet A., Mazerolles F., et al.  Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood. 2019;134:9–21. doi: 10.1182/blood-2018-11-887141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2018-11-887141</ArticleId>
            <ArticleId IdType="pubmed">30940614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahi M.S., Jindal V., Reyes S.P., Gunasekaran K., Gupta R., Jaiyesimi I. Hematologic disorders associated with COVID-19: a review. Ann Hematol. 2021;100:309–320. doi: 10.1007/s00277-020-04366-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00277-020-04366-y</ArticleId>
            <ArticleId IdType="pmc">PMC7789889</ArticleId>
            <ArticleId IdType="pubmed">33415422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W., Giannotta J.A., Fattizzo B. Are patients with autoimmune cytopenias at higher risk of COVID-19 pneumonia? The experience of a reference center in Northern Italy and review of the literature. Front Immunol. 2021;11 doi: 10.3389/fimmu.2020.609198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2020.609198</ArticleId>
            <ArticleId IdType="pmc">PMC7870679</ArticleId>
            <ArticleId IdType="pubmed">33574816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taherifard E., Taherifard E., Movahed H., Mousavi M.R. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases. Hematology. 2021;26:225–239. doi: 10.1080/16078454.2021.1881225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/16078454.2021.1881225</ArticleId>
            <ArticleId IdType="pubmed">33594951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W., Zaninoni A., Fattizzo B., Giannotta J.A., Lunghi M., Ferrari A., et al.  Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. Am J Hematol. 2018;93:E243–E246. doi: 10.1002/ajh.25212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajh.25212</ArticleId>
            <ArticleId IdType="pubmed">29981267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fatizzo B. Evans syndrome and infections: a dangerous cocktail to manage with caution. Blood Transfus. 2021;19:5–8. doi: 10.2450/2021.0351-20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2450/2021.0351-20</ArticleId>
            <ArticleId IdType="pmc">PMC7850928</ArticleId>
            <ArticleId IdType="pubmed">33523800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Monica, Charles B., Yeung N.Z., Sanchez K., Rosen D., Bushan S. Evans syndrome in a patient with COVID-19. Br J Haematol. 2020;18 doi: 10.1111/bjh.16846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjh.16846</ArticleId>
            <ArticleId IdType="pmc">PMC7276874</ArticleId>
            <ArticleId IdType="pubmed">32420629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demir N., Basturk A., Ural O., Sumer S., Erdogdu B., Kiratli H., et al.  A case of Evans syndrome secondary to COVID-19. Blood Transfus. 2021;19:85–88. doi: 10.2450/2020.0221-20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2450/2020.0221-20</ArticleId>
            <ArticleId IdType="pmc">PMC7850926</ArticleId>
            <ArticleId IdType="pubmed">33263526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vadlamudi G., Hong L., Keerthy M. Evans syndrome associated with pregnancy and COVID-19 infection. Case Rep Obstet Gynecol. 2020;2020 doi: 10.1155/2020/8862545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2020/8862545</ArticleId>
            <ArticleId IdType="pmc">PMC7441452</ArticleId>
            <ArticleId IdType="pubmed">32850163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zarza J., Horoch Jv, Aguayo N., Báez E. Evans syndrome associated with antiphospholipid antibodies in a patient with SARS-COV-2 infection. Hematol Transfus Cell Ther. 2020;42:309–312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7441956</ArticleId>
            <ArticleId IdType="pubmed">32864578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Georgy J.T., Jayakaran J., Jacob S.A., Gunasekaran K., Korula P., Devasia A., et al.  Evans syndrome and immune thrombocytopenia in two patients with COVID-19. J Med Virol. 2021:1–3. doi: 10.1002/jmv.26906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmv.26906</ArticleId>
            <ArticleId IdType="pmc">PMC8013600</ArticleId>
            <ArticleId IdType="pubmed">33634495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodríguez Y., Novelli L., Rojas M., Santis M.D., Acosta-Ampudia Y., Monsalve D.M., et al.  Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun. 2020;114 doi: 10.1016/j.jaut.2020.102506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaut.2020.102506</ArticleId>
            <ArticleId IdType="pmc">PMC7296326</ArticleId>
            <ArticleId IdType="pubmed">32563547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Angileri F., Légaré S., Gammazza A.M., de Macario E.C., Macario A.J.L., Cappello F. Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19? Br J Haematol. 2020;190:e92–e93. doi: 10.1111/bjh.16883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjh.16883</ArticleId>
            <ArticleId IdType="pmc">PMC7283741</ArticleId>
            <ArticleId IdType="pubmed">32453861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lippi G., Plebani M., Henry B.M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–148. doi: 10.1016/j.cca.2020.03.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cca.2020.03.022</ArticleId>
            <ArticleId IdType="pmc">PMC7102663</ArticleId>
            <ArticleId IdType="pubmed">32178975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W., Fattizzo B. The changing landscape of autoimmune hemolytic Anemia. Front Immunol. 2020;11:946. doi: 10.3389/fimmu.2020.00946.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2020.00946</ArticleId>
            <ArticleId IdType="pmc">PMC7325906</ArticleId>
            <ArticleId IdType="pubmed">32655543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattacharjee S., Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr Clin Med. 2020:1–11. doi: 10.1007/s42399-020-00521-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s42399-020-00521-8</ArticleId>
            <ArticleId IdType="pmc">PMC7501509</ArticleId>
            <ArticleId IdType="pubmed">32984764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaime-Pérez J.C., Aguilar-Calderón P.E., Salazar-Cavazos L., Gómez-Almaguer D. Evans syndrome: clinical perspectives, biological insights and treatment modalities. J Blood Med. 2018;9:171–184. doi: 10.2147/JBM.S176144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/JBM.S176144</ArticleId>
            <ArticleId IdType="pmc">PMC6190623</ArticleId>
            <ArticleId IdType="pubmed">30349415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terpos E., Ntanasis‐Stathopoulos I., Elalamy I., Kastritis E., Sergentanis T.N., Politou M., et al.  Hematological findings and complications of COVID‐19. Am J Hematol. 2020 doi: 10.1002/ajh.25829.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajh.25829</ArticleId>
            <ArticleId IdType="pmc">PMC7262337</ArticleId>
            <ArticleId IdType="pubmed">32282949</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
